These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4691239

  • 1. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
    Middleton SM, Bennett IH, Smith JK.
    Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
    [No Abstract] [Full Text] [Related]

  • 2. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
    Uszyński L, Poszwiński P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975 May; 102(5):591-4. PubMed ID: 54310
    [Abstract] [Full Text] [Related]

  • 3. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
    Reekers P, Hemker HC.
    Haemostasis; 1972 May; 1(1):2-22. PubMed ID: 4668761
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
    Dike GW, Bidwell E, Rizza CR.
    Br J Haematol; 1972 Apr; 22(4):469-90. PubMed ID: 4112845
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The P.P.S.B. coagulant fraction].
    Soulier JP, Steinbuch M.
    Nouv Presse Med; 1975 Oct 25; 4(36):2581-4. PubMed ID: 812061
    [No Abstract] [Full Text] [Related]

  • 8. Affinity chromatography of coagulation factors II, VIII, IX and X on matrix-bound phospholipid vesicles.
    Andersson LO, Thuy LP, Brown JE.
    Thromb Res; 1981 Sep 15; 23(6):481-9. PubMed ID: 6798706
    [No Abstract] [Full Text] [Related]

  • 9. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Sep 15; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 10. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S.
    Vox Sang; 2003 Nov 15; 85(4):290-9. PubMed ID: 14633255
    [Abstract] [Full Text] [Related]

  • 11. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS, Johnson FF, Robinson JA, Aggeler PM.
    N Engl J Med; 1969 Mar 13; 280(11):581-6. PubMed ID: 5764825
    [No Abstract] [Full Text] [Related]

  • 12. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T, Michalski C, Goudemand M, Huart JJ.
    Vox Sang; 1989 Mar 13; 57(4):225-32. PubMed ID: 2617959
    [Abstract] [Full Text] [Related]

  • 13. Coagulation factor IX in normal and haemophilia B plasma.
    Somer JB, Castaldi PA.
    Br J Haematol; 1970 Feb 13; 18(2):147-59. PubMed ID: 5439522
    [No Abstract] [Full Text] [Related]

  • 14. [A human plasma fraction (PPSB) enriched with the coagulation factors II, VII, IX and X].
    Richter K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Feb 13; 93(3):340-3. PubMed ID: 4195279
    [No Abstract] [Full Text] [Related]

  • 15. Preparation and clinical use of P.P.S.B. (factors II, VII, X and IX concentrate).
    Soulier JP, Ménaché D, Steinbuch M, Blatrix C, Josso F.
    Thromb Diath Haemorrh Suppl; 1968 Feb 13; 35():61-72. PubMed ID: 5761074
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Editorial: Factor VIII inhibitors.
    Deykin D.
    N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491
    [No Abstract] [Full Text] [Related]

  • 18. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
    Ahmad SS, Rawala-Sheikh R, Thompson AR, Walsh PN.
    Thromb Res; 1989 Jul 01; 55(1):121-33. PubMed ID: 2781515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Advances in the field of hemophilia therapy].
    Loeliger EA, Veltkamp JJ.
    Ned Tijdschr Geneeskd; 1968 Sep 07; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.